New electroporation treatment versus standard care for enlarged prostate
Part of Kidney & urinary clinical trials.
This trial tests a newer, minimally invasive treatment (high-frequency irreversible electroporation) against standard treatments for an enlarged prostate causing urinary symptoms. The goal is to see if this approach relieves symptoms with fewer side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have moderate-to-severe urinary symptoms from an enlarged prostate (IPSS score of 13 or higher)
- Your prostate is between 30 and 150 milliliters in size, measured by MRI or ultrasound
- Your maximum urinary flow rate is 15 milliliters per second or slower
- You have no history of prostate cancer, prostate surgery, or pelvic radiation
- You can safely stop blood-thinning medications if the treatment requires it
- You are able to attend follow-up appointments and provide informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a non-invasive treatment using high-intensity focused ultrasound (HIFU) to reduce prostate tissue that blocks urine flow. It may help men with moderate to severe urinary symptoms from an enlarged prostate who haven't had success with or can't take medication.
This trial compares two ways of treating localized prostate cancer: H-FIRE versus laparoscopic prostate surgery. It may help find which approach works best for people with early-stage, non-spread prostate cancer.
This trial tests a new minimally invasive procedure called irreversible electroporation (IRE)—which uses electrical pulses to treat prostate tissue—to relieve urinary symptoms caused by an enlarged prostate. The goal is to improve urinary flow and reduce bothersome symptoms without major surgery.
This trial tests a focused ultrasound treatment for benign prostatic hyperplasia (BPH), which is a non-cancerous enlargement of the prostate. It aims to see if HIFU can safely relieve symptoms like weak urine flow and frequent urination.
This trial tests a new, non-surgical treatment called irreversible electroporation (IRE) for men with early-stage prostate cancer that hasn't spread. It uses short electrical pulses to destroy cancer cells while sparing healthy tissue nearby.
This study compares two minimally invasive procedures for treating an enlarged prostate: one uses a laser (holmium enucleation) and the other uses a robotic water jet. The goal is to see which treatment better improves urinary symptoms caused by an enlarged prostate.
Hear when a new BPH trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.